Deinove (XPAR:ALDEI) Change In Receivables : €0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is Deinove Change In Receivables?

Deinove's change in receivables for the quarter that ended in Jun. 2022 was €0.00 Mil. It means Deinove's Accounts Receivable stayed the same from Dec. 2021 to Jun. 2022 .

Deinove's change in receivables for the fiscal year that ended in Dec. 2021 was €0.00 Mil. It means Deinove's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Deinove's Accounts Receivable for the quarter that ended in Jun. 2022 was €0.11 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Deinove's Days Sales Outstanding for the six months ended in Jun. 2022 was 164.84.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Deinove's liquidation value for the six months ended in Jun. 2022 was €-20.30 Mil.

Deinove Change In Receivables Historical Data

The historical data trend for Deinove's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Change In Receivables Chart

Deinove Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

Deinove Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Deinove Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Deinove (XPAR:ALDEI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Deinove's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.112	/	0.124	*	91
=	164.84

2. In Ben Graham's calculation of liquidation value, Deinove's accounts receivable are only considered to be worth 75% of book value:

Deinove's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.102	-	21.486	+	0.75 * 0.112	+	0.5 * 0
=	-20.30

Deinove Change In Receivables Related Terms

Thank you for viewing the detailed overview of Deinove's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Deinove (XPAR:ALDEI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790

Website

http://www.deinove.com

Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines